FDA approves Amgen drug for tough-to-treat type of lung most cancers

Imdelltra, a bispecific antibody focusing on a protein known as DLL3, is cleared to be used following chemotherapy in treating extensive-stage small cell lung most cancers.

Jonathan Gardner Member since November 15, 2023

Loading + Follow Following